Search research articles
Contact Us
Filters
Showing results (121-130 of 318) with videos related to
Page
of 32
Sort By:
The American Journal of Gastroenterology
|
December 7, 2010
Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series
Patrick R Kenny, Daniel E Brady, Dawn M Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 20, 2020
Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease
Donghee Kim, Soumya Murag, George Cholankeril, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2009
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study
Daniel E Brady, Dawn M Torres, Jong W An, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
October 1, 2005
An AFLP-based survey of genetic diversity among accessions of sea oats (Uniola paniculata, Poaceae) from the southeastern Atlantic and Gulf coast states of the United States
Prasanta K Subudhi, Neil P Parami, Stephen A Harrison, et al.
Gastroenterology & Hepatology
|
July 1, 2014
Controversies in the Diagnosis and Management of NAFLD and NASH
Mary E Rinella, Rohit Loomba, Stephen H Caldwell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 22, 2023
MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death
Emily Truong, Jeffrey A Gornbein, Ju Dong Yang, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2009
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis
Amalia Gastaldelli, Stephen A Harrison, Renata Belfort-Aguilar, et al.
Hepatology Communications
|
April 16, 2021
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH
Stephen A Harrison, Mustafa Bashir, Sam E Moussa, et al.
Combinatorial Chemistry & High Throughput Screening
|
June 3, 2017
High Throughput Screening Assay to Identify Modulators of IL-17 Expression
Mohamed Boudjelal, Ana Maria Ruiz-Avendano, Gonzalo Colmenarejo, et al.
Hepatology (Baltimore, Md.)
|
February 16, 2012
Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin
Stephen A Harrison, Fayez M Hamzeh, Jian Han, et al.
Page
of 32
Search research articles
Search
Showing results (121-130 of 318) with videos related to
Sort By:
Page
of 32
The American Journal of Gastroenterology
|
December 7, 2010
Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series
Patrick R Kenny, Daniel E Brady, Dawn M Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 20, 2020
Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease
Donghee Kim, Soumya Murag, George Cholankeril, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2009
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study
Daniel E Brady, Dawn M Torres, Jong W An, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
October 1, 2005
An AFLP-based survey of genetic diversity among accessions of sea oats (Uniola paniculata, Poaceae) from the southeastern Atlantic and Gulf coast states of the United States
Prasanta K Subudhi, Neil P Parami, Stephen A Harrison, et al.
Gastroenterology & Hepatology
|
July 1, 2014
Controversies in the Diagnosis and Management of NAFLD and NASH
Mary E Rinella, Rohit Loomba, Stephen H Caldwell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 22, 2023
MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death
Emily Truong, Jeffrey A Gornbein, Ju Dong Yang, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2009
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis
Amalia Gastaldelli, Stephen A Harrison, Renata Belfort-Aguilar, et al.
Hepatology Communications
|
April 16, 2021
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH
Stephen A Harrison, Mustafa Bashir, Sam E Moussa, et al.
Combinatorial Chemistry & High Throughput Screening
|
June 3, 2017
High Throughput Screening Assay to Identify Modulators of IL-17 Expression
Mohamed Boudjelal, Ana Maria Ruiz-Avendano, Gonzalo Colmenarejo, et al.
Hepatology (Baltimore, Md.)
|
February 16, 2012
Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin
Stephen A Harrison, Fayez M Hamzeh, Jian Han, et al.
Page
of 32